BioSpace News Archive

Pharm Country

PaxMedica Announces 1-for-17 Reverse Stock Split

PaxMedica, Inc. announced that as a result of its 1-for-17 reverse stock split of its common stock that became effective at 8:03 a.m. Eastern Time on October 30, 2023, its common stock will begin trading on a split-adjusted basis with the open of the market on October 31, 2023.

October 30, 2023
·
2 min read
BioMidwest

Transpire Bio Expands Access and Innovation in Inhalation Therapies with New Research and Manufacturing Facility

Transpire Bio, a development-stage biopharmaceutical company, was joined by local and state elected officials and industry leaders to celebrate the opening of its new research facility and global headquarters in Weston.

October 30, 2023
·
2 min read
Genetown

Porosome Therapeutics Announces Groundbreaking Approach to Advance Diabetes Treatment

Porosome Therapeutics, Inc. has announced a new and distinctive therapy for Type 1 Diabetes and Type 2 Diabetes targeting the insulin secretory defects founds in beta cells associated with the disease.

October 30, 2023
·
4 min read
Business

Angstrom Technology Announces Jennifer Biro as President of New Life Sciences Division

Angstrom Technology is thrilled to announce a new addition to its world class leadership team with the hiring of Jennifer Biro in role of President for its newly formed Life Sciences Division.

October 30, 2023
·
2 min read
Genetown

bluebird bio Enters into Advance Agreement to Sell Priority Review Voucher, if Granted, for $103 Million

bluebird bio, Inc. announced that it has entered into an agreement to sell a Rare Pediatric Disease Priority Review Voucher, if received, in connection with the potential approval of lovotibeglogene autotemcel for sickle cell disease.

October 30, 2023
·
6 min read
Business

Astria Therapeutics to Report Third Quarter 2023 Financial Results and Provide a Corporate Update on Monday, November 13th

Astria Therapeutics to Report Third Quarter 2023 Financial Results and Provide a Corporate Update on Monday, November 13th.

October 30, 2023
·
1 min read
Business

Harrow Will Release Third Quarter 2023 Financial Results on November 13, 2023

Harrow (Nasdaq: HROW), a leading U.S. eyecare pharmaceutical company, today announced that it will release its financial results for the third quarter ended September 30, 2023, on Monday, November 13, 2023, after the market close.

October 30, 2023
·
1 min read
Genetown

Avilar Therapeutics to Present New Data for ATAC Extracellular Protein Degraders at Targeted Protein Degradation Summit

Avilar Therapeutics today announced it will present new preclinical data from its ATAC (ASGPR Targeting Chimera) degrader platform at the sixth annual Targeted Protein Degradation Summit being held in Boston on October 30 – November 2, 2023.

October 30, 2023
·
2 min read
Business

Stan Lapidus Joins Calviri’s Scientific Advisory Board

Calviri, Inc. announced that Stan Lapidus, the founder of Cytyc Corporation and EXACT Sciences, has been elected to join Calviri’s Scientific Advisory Board.

October 30, 2023
·
2 min read
Biotech Bay

Enable Medicine to Present Poster Presentations at the Society for Immunotherapy of Cancer (SITC) 2023 Annual Meeting

Enable Medicine , a leader in AI for biological research and drug discovery, announced today it will present a number of poster presentations at the Society for Immunotherapy of Cancer (SITC) 38th Annual Meeting being held November 1-5, 2023, in San Diego, California.

October 30, 2023
·
3 min read